Androgen Deprivation Therapy in Advanced Salivary Gland Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

September 24, 2015

Primary Completion Date

August 23, 2023

Study Completion Date

February 16, 2024

Conditions
Salivary Gland Cancer
Interventions
DRUG

bicalutamide + triptorelin

DRUG

Cisplatin + Doxorubicin

DRUG

Carboplatin + Paclitaxel

Trial Locations (26)

1000

Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet, Brussels

1090

Medical University Vienna - General Hospital AKH, Vienna

1122

National Institute Of Oncology, Budapest

1200

Cliniques Universitaires Saint-Luc, Brussels

2020

ZNA Middelheim, Antwerp

2650

Universitair Ziekenhuis Antwerpen, Edegem

12200

Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin

12462

Athens University - Attikon University General Hospital, Athens

24127

Azienda Ospedaliera Papa Giovanni XXIII, Bergamo

31059

Institut Universitaire du Cancer de Toulouse (IUCT) Oncopole - Institut Claudius Regaud, Toulouse

33075

CHU de Bordeaux - Groupe Hospitalier Saint-André - Hopital Saint-Andre, Bordeaux

38100

Azienda Provinciale per i Servizi Sanitari - Ospedale Santa Chiara, Trento

44805

Institut de Cancerologie de l'Ouest (ICO) - Centre Rene Gauducheau, Nantes

54519

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

75020

Assistance Publique - Hopitaux de Paris - Hopital Tenon, Paris

Unknown

U.Z. Leuven - Campus Gasthuisberg, Leuven

Institut régional du Cancer Montpellier, Montpellier

CHU de Nantes - Hotel Dieu, Nantes

Gustave Roussy, Villejuif

Universitaetsklinikum Leipzig-Ambulanzen/Sprechstunden, Leipzig

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

Radboud University Medical Center Nijmegen, Nijmegen

06189

Centre Antoine Lacassagne, Nice

07747

Universitaetsklinikum Jena-Radiation Therapy and Radiooncology Clinic, Jena

1007MB

Spaarne Gasthuis - Vrije Universiteit Medisch Centrum, Amsterdam

9713 GZ

University Medical Center Groningen (UMCG), Groningen

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT01969578 - Androgen Deprivation Therapy in Advanced Salivary Gland Cancer | Biotech Hunter | Biotech Hunter